Elizabeth Dragon, Central Figure in Sequenom Trisomy 21 Scandal, Dies
May 05, 2011
Elizabeth Dragon, Central Figure in Sequenom Trisomy 21 Scandal, Dies
The former R&D executive at Sequenom was to be sentenced in the summer for making "materially false and misleading statement" about the Trisomy 21 test.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Pairings
September 30, 2009 / Pharmacogenomics Reporter - MaterniT21 Doubles Sequenom's Revenues; Firm Inks Deal with Blue Cross Blue Shield Association
May 15, 2013 / Clinical Sequencing News - Credit Suisse Upgrades Sequenom to Neutral
May 13, 2013 / GenomeWeb Daily News - Experts Weigh in on Ethical Considerations for NIPT at Biology of Genomes Panel
May 10, 2013 / GenomeWeb Daily News - Sequenom's Q1 Revenues More than Double
May 10, 2013 / GenomeWeb Daily News